STRATA Skin Sciences, Inc. — Director's Dealing 2009

May 26, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELECTRO OPTICAL SCIENCES INC /NY (MELA)
CIK: 0001051514
Period of Report: 2009-05-22

Reporting Person: Gulfo Joseph V (Director, CEO & President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-10-10	Stock Option	$3.75	A	180000	Acquired	2018-10-10	Common Stock (180000)	Direct

Footnotes

F1: On October 10, 2008, Dr. Gulfo was granted stock options for 900,000 shares of the Issuer's common stock. These shares have an exercise price of $3.75 per share, which was the current market price at the date of the grant. This grant vests as follows: (i) with respect to 180,000 shares, immediately (the "Vested Shares"); (ii) with respect to 540,000 shares, upon the Issuer receiving approval from the Food and Drug Administration for a pre-market approval application for MelaFind; and (iii) with respect to 180,000 shares, in four equal annual installments commencing on October 10, 2009 (the "Annual Shares"). The Annual Shares were issued subject to stockholder approval, which was obtained at the Issuer's Annual Meeting held on May 22, 2009, and accordingly are now being reported in this Form 4. The Vested Shares were previously reported in a Form 4 filed with the SEC on October 15, 2008.